20 anni di Epidemiologia delle Malattie Respiratorie Dr. Giovanni Viegi. Direttore f.f., Istituto di Biomedicina e Immunologia Molecolare “Alberto Monroy” CNR, Palermo. Responsabile Scientifico, Unità di Ricerca di Epidemiologia Ambientale Polmonare, Istituto di Fisiologia Clinica CNR, Pisa. Professore di “Effetti dell’inquinamento sulla salute”, Corso di Laurea in Scienze Ambientali, Università di Pisa. September 2006-September 2007 Past President, European Respiratory Society (ERS) Past Member of Planning Group, Global Alliance against chronic Respiratory Diseases (GARD)
Mortality
A B
CNR Epidemiological surveys
PO DELTA PISA
Materials and methods I Po Delta area, North Italy 1st cross-sectional study (PD1): - carried out in , before operation of a large oil-burning thermoelectric power plant subjects (78% of expected, age 8-64 yr) 2nd cross-sectional study (PD2): - performed in subjects (age 8-73 yr) Pisa, Central Italy 1st cross-sectional survey (PI1): - performed in subjects (77% of expected, age 5-90 yr) 2nd cross-sectional study (PI2): - carried out in , after the construction of a new highway connecting Pisa to Florence subjects (age 8-97 yr)
Materials and methods II PD study Modified NHBLI questionnaire developed by CNR Special Project on chronic obstructive lung disease (COLD), containing > 70 questions regarding respiratory symptoms, diseases and risk factors Lung function tests Skin prick tests, total serum IgE, bronchial responsiveness to methacholine challenge (PD2) PI study Modified NHBLI questionnaire developed by CNR Special Project on chronic obstructive lung disease (COLD), containing a new part on daily activity pattern Lung function tests (PI2) Skin prick tests, total serum IgE, bronchial responsiveness to methacholine challenge (PI2) Mutagenetic determinations (sister chromatid exchanges, micronuclei), hemoglobin and DNA adducts to benzo(a)pyrene (PI2)
Po River Delta Lung function: American Thoracic Society protocol “47804S Hewlett Packard” pneumotachograph Pisa Lung function (2nd survey only): American Thoracic Society protocol Water sealed spirometer Baires, Biomedin Materials and methods IV Spirometry
Baldacci et al, J Environ Pathol Toxicol Oncol 1997
Prevalence, incidence of respiratory symptoms/diseases and risk factors
(1999)
Viegi, Int J Tuberc Lung Dis 1999
Viegi, Chest 2000
Viegi, Chest 2004
Viegi, Eur J Epidemiol 1994
Figure 2 Classification of subjects based on the distance of each home from the main road. Zoomed map representing the classification of subjects according to the distance of each home from the main road. Highly exposed subjects are those living in the buffer area m from the road, moderately exposed subjects living in the buffer area m and unexposed are those living between 250 and 800 m from the road. Pisa Study
Guerra, Allergy 2005
Lung function
Methods Natural cubic spline models over the whole age range two “breakpoints” to split the growth, plateau and decline phases
Pistelli, AJRCCM 2000
Pistelli, Respir Med 2007
Viegi, Chest 2001
Pistelli, Respir Med 2008
Bronchial hyperresponsiveness
Paoletti, AJRCCM 1995
Maio, Chest 2009
Indoor air pollution
Arch Environ Health 2002
Simoni, J Expo Anal Environ Epidemiol 2004
Risks to get respiratory symptoms
Risks to get elevated maximum amplitude and diurnal variation of peak expiratory flow (PEF) Simoni, J Expo Anal Environ Epidemiol 2004
Mutagenetic evaluations
Barale, Environ Mol Mut 1998
Petruzzelli, Cancer Research, 1998
Skin prick test and IgE
Baldacci, Allergy 1996
SEASD Study
Simoni, Clin Chem Lab Med 2006
Studio SEASD Population attributable risk (PAR%): eliminando entrambe le esposizioni al partner e al lavoro si potrebbe ridurre il rischio di sintomi e malattie respiratorie considerate: da un minimo del 5% per fischi e diagnosi di asma ad un massimo del 24% per difficoltà di respiro a riposo. OLD, diagnosi di asma e/o bronchite cronica/enfisema
Medicine consumption
sub years
Simoni, Respir Med 2008
AIFA funded projects
Baldacci, Respir Med 2012
Maio, Curr Med Res Opin 2012
Maio, J Asthma 2012
GARD and Italian Ministry funded projects
Bousquet, ERJ 2010 Eur Respir J Nov;36(5):
Acting Director, CNR Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, Palermo, Italy Head, Pulmonary Environmental Epidemiology Unit, CNR Institute of Clinical Physiology, Pisa, Italy Professor of “Health Effects of Pollution”, School of Environmental Sciences, University of Pisa, Italy Past-President, European Respiratory Society (ERS) Member of Planning Group, Global Alliance against chronic Respiratory Diseases (GARD) Chief Medical Officers Meeting Italian Presidency of European Council Rome, October 6, 2014 “Burden of chronic respiratory disease in Europe” Giovanni Viegi
COMODHES STUDY
Maio, Curr Med Res Opin 2014
Maio, Curr Med Res Opin 2014
Viegi & coll. Risk charts for COPD (National Institute of Health)
Viegi & coll. Risk charts for COPD (National Institute of Health)
Community Acquired Pneumonia (CAP)
Viegi, Respir Med 2006
Task Force participations
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). ERS Consensus Statement Siafakas NM, Vermeire P, Pride NB, Paoletti P……., on behalf of the Task Force ……….Viegi G, De Backer W, Georgopoulos D, McNee W, Russi E, Stanescu D. Weitzenblum E, Howard P, Del Donno M, Donner H, Lode H, Lofdahl CG, Olivieri D, Robert D, et al Eur Respir J 1995; 8: The pharmacoepidemiology of COPD: recent advances and methodological discussion. Burney P, Suissa S, Soriano JB, Vollmer WM, Viegi G, Sullivan SD, Fabbri LM, Sin DD, Ernst P, Coultas D, Bourbeau J, Mapel DW, Weiss K, McLaughlin T, Price D, Sturkenboom MC, Taylor R, Hagan GW Eur Respir J 2003;43:1s-44s.
Pellegrino, Eur Respir J 2005
Maio, Eur Respir J 2012
Review Articles
Part I of II Cough Phlegm Wheeze Attacks of wheeze Chronic bronchitis Emphysema Asthma MEN
MALES Viegi’s part
Smoking cessation
Carrozzi, Int J Environ Res Public Health 2014
Other epidemiological research groups connected to SIMeR
HESE Study
Simoni, Eur Respir J 2010
Simoni, Pediatr Allergy Immunol 2011
Am J Respir Crit Care Med 1994
SIDRIA Studi Italiani sui Disturbi Respiratori nell’Infanzia e l’Ambiente
Centres who participated in ECRHS ( ), in ISAYA ( ) and GEIRD ( ) surveys in Italy according to climatic region
Prevalenza di asma corrente e rinite allergica in Italia dal 1991 al 2010 (4 centri :Pavia, Torino, Verona, Sassari) (popolazione generale adulti tra 20 e 45 anni) ) Asma corrente Rinite allergica de Marco, Cerveri et al; ERJ 2012
ISAYA Study; 6 Italian centres 214 subjects with current asthma followed up for 9 years
CHANGES IN ASTHMA CONTROL ISAYA Study 147 subjects with active asthma at follow-up Controlled asthma Uncontrolled asthma Partially controlled asthma 41% 28% 31% 1999 (at baseline) 2009 (follow-up) 23% 27% Controlled asthma Uncontrolled asthma Partially controlled asthma 50%
Prevalence of reported doctor diagnosis of COPD, CB and Emphysema in ITALY * GEIRD GEIRD age Prevalence % (95% CI) ( ) ( ) ( ) ( ) 8.5 ( ) * Survey carried out on random samples from the general population of Verona, Pavia, Torino, Sassari and Palermo. De Marco, Cerveri et Plos One 2013
Pisa – Po Delta team: main collaborators of Giovanni Viegi Carlo Giuntini (retired) Giuseppe Pistelli (†) Tristano Sapigni (†) Paolo Paoletti Piera Fazzi (retired) Francesco Di Pede (retired) Laura Carrozzi Marzia Simoni Francesco Pistelli Sandra Baldacci Matteo Bottai Sara Maio Sonia Cerrai Giuseppe Sarno Paola Modena Marzia Pedreschi Mariella Vellutini Emilio Diviggiano Licia Ballerin Patrizia Biavati Umberto Mammini (†) Roberto Barale Gabriella Matteelli Antonio Scognamiglio Anna Angino Franca Martini Patrizia Silvi
“Grazie per l’invito e per l’attenzione” Giovanni Viegi